Focusing on new monoamine oxidase inhibitors: Differently substituted coumarins as an interesting scaffold

Current Topics in Medicinal Chemistry

Volumn 12, Issue 20, 2012, Pages 2210-2239

  Matos, Maria Joáo ^a   Viña, Dolores ^a   Vazquez Rodriguez, Saleta ^a   Uriarte, Eugenio ^a   Santana, Lourdes ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Alzheimer disease; Coumarins; MAO inhibitors; Monoamine oxidase; Parkinson disease

Indexed keywords

COUMARIN DERIVATIVE; MONOAMINE OXIDASE INHIBITOR;

AGING; ALZHEIMER DISEASE; BROMINATION; DEGENERATIVE DISEASE; ETHERIFICATION; HUMAN; IC 50; KNOEVENAGEL CONDENSATION; PARKINSON DISEASE; PATHOGENESIS; REVIEW; STRUCTURE ACTIVITY RELATION; SUZUKI REACTION; WILLIAMSON REACTION; WITTIG REACTION;

EID: 84874893498     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/156802612805220002     Document Type: Review

References (108)

1. Tipton, K. F. Enzymology of monoamine oxidase. Cell. Biochem.Funct., 1986, 4, 79-87.
2. Dostert, P.; Strolin, B. M.; Jafre, M. Monoamine oxidase: basic and clinical frontiers. In Excerpta Medica; Elsevier: Amsterdan, 1982, pp. 197.
3. Singer, T. P. In Chemistry and Biochemistry of Flavoenzymes; Muller, F., Ed.; CRC Press: Boca Raton FL, 1991; Vol. 2, pp. 437.
4. Youdim, M. B.; Bakhle, Y. S. Monoamine oxidase: isoforms and inhibitors in Parkinsońs disease and depressive illness. Br. J. Pharm., 2006, 147, S287-S296.
5. Youdim, M. B.; Finberg, J. P. M.; Tipton, K. F. Monoamine oxidase. In: Advances in Experimental Pharmacology. Catecholamine. II. ed. Trendelenburg, U. & Weiner, U., Berlin: Springer-Verlag, 1988, pp. 119-192.
6. Bach, A. W. J.; Lan, N. C.; Johnson, D. L.; Abell, C. W.; Bem- benek, M. E.; Kwan, S. W.; Seeburg, P. H.; Shih, J. C. cDNA clon- ing of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc. Natl. Acad. Sci. U S A, 1988, 85, 4934-4938.
7. Wouters, J. Structural aspects of monoamine oxidase and its reversible inhibition. Curr. Med. Chem., 1998, 5, 137-162.
8. Grimsby, J.; Lan, N. C.; Neve, R.; Chen, K.; Shih, J. C. Tissue distribution of human monoamine oxidase A and B mRNA. J. Neurochem., 1990, 55, 1166-1169.
9. Kalgutkar, A. S.; Castagnoli, N.; Testa, B. Selective inhibitors of monoamine oxidase (MAO-A and MAO-B) as probes of its catalytic site and mechanism. Med. Res. Rev., 1995, 15, 325-388.
10. Geha, R. M.; Rebrin, I.; Chen, K.; Shih, J. C. Substrate and inhibi- tor specificities for human monoamine oxidase A and B are influenced by a single amino acid. J. Biol. Chem., 2001, 276, 9877-9882.
11. Ma, J.; Yoshimura, M.; Yamashita, E.; Nakagawa, A.; Ito, A.; Tsukihara, T. Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors. J. Mol. Biol., 2004, 338, 103-115.
12. Weyler, W.; Hsu Yun P. P.; Breakefield, X. O. Biochemistry and genetics of monoamine oxidase. Pharmacol. Ther., 1990, 47, 391-417.
13. Smith, R. G. The aging process: where are the drug opportunities? Curr. Opin. Chem. Biol., 2000, 4, 371-376.
14. Binda, C.; Newton-Vinson, P.; Hubalek, F.; Edmondson, D. E.; Mattevi, A. Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders. Nat. Struct. Mol. Biol., 2002, 9, 22-26.
15. Binda, C.; Li, M.; Hubálek, F.; Restelli, N.; Edmondson, D. E.; Mattevi, A. Insights into the mode of inhibition of human mito-chondrial monoamine oxidase B from high-resolution crystal structures. Proc. Natl. Acad. Sci. U S A, 2003, 100, 9750-9755.
16. De Colibus, L.; Li, M.; Binda, C.; Lustig, A.; Edmondson, D. E.; Mattevi, A. Three-dimensional structure of human monoamine oxidase A (MAO-A): Relation to the structures of rat MAO-A and human MAO B. Proc. Natl. Acad. Sci. U S A, 2005, 102, 12684-12689.
17. Binda, C.; Hubalek, F.; Li, M.; Herzig, Y.; Sterling, J.; Edmond- son, D. E.; Mattevi, A. Crystal structures of monoamine oxidase B in complex with four inhibitors of the N-propargylaminoindane class. J. Med. Chem., 2004, 47, 1767-1774.
18. Milczek, E. M.; Bonivento, D.; Binda C.; Mattevi, A.; McDonald, I. A.; Edmondson, D. E. Structural and mechanistic studies of mofegiline inhibition of recombinant human monoamine oxidase B. J. Med. Chem., 2008, 51, 8019-8026.
19. Brunner, H. G.; Nelen, M.; Breakefield, X. O.; Ropers H. H.; van Oost B. A. Abnormal behaviour associated with a point mutation in the structural gene for monoamine oxidase A. Science, 1993, 262, 578-580.
20. Caspi, A.; McClay, J.; Moffitt, T. E.; Mill, J.; Martin, J.; Craig, I. W.; Taylor, A.; Poulton, R. Role of genotype in the cycle of violence in maltreated children. Science, 2002, 297, 851-854.
21. Meyer, J. H.; Ginovart, N.; Boovariwala, A.; Sagrati, S.; Hussey, D.; García, A.; Young, T.; Praschak-Rieder, N.; Wilson, A. A.; Houle, S. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch. Gen. Psych., 2006, 63, 1209-1216.
22. Thorpe, L.; Groulx, B. Depressive syndromes in dementia. Can. J. Neurol. Sci., 2001, 28, 83-95.
23. Nishimura, A. L.; Guindalini, C.; Oliveira, J. R.; Nitrini, R.; Bahia, V. S.; de Brito-Marques, P. R.; Otto, P. A.; Zatz, M. Monoamine oxidase a polymorphism in Brazilian patients: risk factor for late-onset Alzheimeŕs disease? J. Mol. Neurosci., 2005, 27, 213-217.
24. Wu, C. K.; Mesulam, M. M.; Geula, C. Age-related loss of calbindin from human basal forebrain cholinergic neurons. Neuroreport., 1997, 8, 2209-2213.
25. Emilsson, L.; Saetre, P.; Balciuniene, J.; Castensson, A.; Cairns, N.; Jazin, E. E. Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimeŕs disease patients. Neurosci. Lett., 2002, 326, 56-60.
26. Takehashi, M.; Tanaka, S.; Masliah, E.; Ueda, K. Association of monoamine oxidase A gene polymorphism with Alzheimeŕs disease patients. Neurosci. Lett., 2002, 327, 79-82.
27. Amrein, R.; Martin, J. R.; Cameron A. M. Moclobemida in patients with dementia and depression. Adv. Neurol., 1999, 80, 509-519.
28. Gareri, P.; Falconi, U.; De Fazio, P.; De Sarro, G. Conventional and new antidepressant drugs in the eldery. Prog. Neurobiol., 2000, 61, 353-396.
29. Maragos, W. F.; Young, K. L.; Altman C. S.; Pocernich, C. B.; Drake, J.; Butterfield, D. A.; Seif, I.; Holschneider, D. P.; Chen, K.; Shih J. C. Strial damage ans oxidative stress induced by the mito-chondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice. Neurochem. Res., 2004, 29, 741-746.
30. Ou, X. M.; Chen K.; Shih J. C. Monoamine oxidase A and repressor RI are envolved in apoptotic signaling pathway. Proc. Natl. Acad. Sci. U S A, 2006, 103, 10923-10928.
31. Gerlach, M.; Double, K.; Reichmann, H.; Riederer, P. Arguments for the use of dopamine receptor agonists in clinical and preclinical Parkinsońs diseases. J. Neural Transm. Suppl., 2003, 167-193.
32. Fernandez, H. H.; Chen, J. J. Monamine oxidase inhibitors: current and emerging agents for Parkinson disease. Clin. Neuropharmacol., 2007, 30, 150-168.
33. Riederer, P.; Danielczyk, W.; Grunblatt, E. Monoamine oxidase-B inhibition in Alzheimeŕs disease. Neurotoxicology, 2004, 25, 271-277.
34. Saura, J.; Luque J. M.; Cesura, A. M.; Da Prada, M.; Chan-Palay, V.; Huber, G.; Loffler, J.; Richards, J.G. Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience, 1994, 62, 15-30.
35. McLellan, M. E.; Kajdasz, S. T.; Hyman, B. T.; Bacskai, B. J. In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy. J. Neurosci., 2003, 23, 2212-2217.
36. Magyar, K.; Szende, B. Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties. Neurotoxicology, 2004, 25, 233-242.
37. Youdim, M. B.; Edmondson, D.; Tipton, K. F. The therapeutic potential of monoamine oxidase inhibitors. Nat. Rev. Neurosci., 2006, 7, 295-309.
38. Murray, R. D. H.; Mendez, J.; Brown, S. A. The natural coumarins occurrence. In Chemistry and Biochemistry; John Wiley and Sons: Chichester, 1982.
39. Murray, R. D. H. Naturally occurring plant coumarins. Prog. Chem. Org. Nat. Prod., 2002, 83, 1-673.
40. Borges, F.; Roleira, F.; Milhazes, N.; Santana, L.; Uriarte, E. Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity. Curr. Med. Chem., 2005, 12, 887-916.
41. Borges, F.; Roleira, F.; Milhazes, N.; Uriarte, E.; Santana, L. Simple Coumarins: Privileged Scaffolds in Medicinal Chemistry. Front. Med. Chem., 2009, 4, 23-85.
42. O'Kennedy, R. Coumarins. Biology, applications and mode of action, Thornes R.D. (Ed), John Wiley and Sons: New York, 1997.
43. Belluti, F.; Fontana, G.; Bo, L.; Carenini, N.; Giommarelli, C.; Zunino, F. Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: identification of novel proapoptotic agents. Bioorg. Med. Chem., 2010, 18, 3543-3550.
44. Riveiro, M. E.; Moglioni, A.; Vazquez, R.; Gomez, N.; Facorro, G.; Piehl, L.; de Celis, E. R.; Shayo, C.; Davio, C. Structural in- sights into hydroxycoumarin-induced apoptosis in U-937 cells. Bioorg. Med. Chem., 2008, 16, 2665-2675.
45. Fylaktakidou, K. C.; Hadjipavlou-Litina, D. J.; Litinas, K. E.; Nicolaides, D. N. Natural and synthetic coumarin derivatives with anti- inflammatory/antioxidant activities. Curr. Pharm. Des., 2004, 10, 3813-3833.
46. Roussaki, M.; Kontogiorgis, C.; Hadjipavlou-Litina, D. J.; Hami- lakis, S. A novel synthesis of 3-aryl coumarins and evaluation of their antioxidant and lipoxygenase inhibitory activity. Bioorg. Med. Chem. Lett., 2010, 20, 3889-3892.
47. Vilar, S.; Quezada, E.; Santana, L.; Uriarte, E.; Yanez, M.; Fraiz, N.; Alcaide, C.; Cano, E.; Orallo, F. Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin-resveratrol hybrids. Bioorg. Med. Chem. Lett., 2006, 16, 257-261.
48. Ostrov, D. A.; Hernández Prada, J. A.; Corsino, P. E.; Finton, K. A.; Le, N.; Rowe, T. C. Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening. Antimicrob. Agents Chemother., 2007, 51, 3688-3698.
49. Chimenti, F.; Bizzarri, B.; Bolasco, A.; Secci, D.; Chimenti, P.; Granese, A.; Carradori, S.; Rivanera, D.; Zicari, A.; Scaltrito, M. M.; Sisto, F. Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3- carboxamides. Bioorg. Med. Chem. Lett., 2010, 20, 4922-4926.
50. Neyts, J.; De Clercq, E.; Singha, R.; Chang, Y. H.; Das, A. R.; Chakraborty, S. K.; Hong, S. C; Tsay, S.-C; Hsu, M.-H.; Hwu, J. R. Structure-activity relationship of new anti-Hepatitis C virus agents: heterobicycle-coumarin conjugates. J. Med. Chem., 2009, 52, 1486-1490.
51. Kostova, I. Coumarins as inhibitors of HIV reverse transcriptase. Curr. HIV Res., 2006, 4, 347-363.
52. Chilin, A.; Battistutta, R.; Bortolato, A.; Cozza, G.; Zanatta, S.; Poletto, G.; Mazzorana, M.; Zagotto, G.; Uriarte, E.; Guiotto, A.; Meggio, F.; Moro, S. Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure-activity relationships. J. Med. Chem., 2008, 51, 752-759.
53. Zhou, X.; Wang, X. B.; Wang, T.; Kong, L. Yi. Design, synthesis, and acetylcholinesterase inhibitory activity of novel coumarin analogues. Bioorg. Med. Chem., 2008, 16, 8011-8021.
54. Garino, C; Tomita, T.; Pietrancosta, N.; Laras, Y.; Rosas, R.; Herbette, G.; Maigret, B.; Quéléver, G.; Iwatsubo, T.; Kraus, J. L. Naphthyl and coumarinyl biarylpiperazine derivatives as highly potent human p-secretase inhibitors. Design, synthesis, and enzymatic BACE-1 and cell assays. J. Med. Chem., 2006, 49, 4275-4285.
55. Kadir, H. A.; Knowles, C. O. Inhibition of rat brain monoamine oxidase by insecticides, acaricides and related compounds Gen. Pharmacol, 1981, 12, 239-247.
56. Rendenbach, B.; Weifenbach, H.; Teschendorf, H. J. Preparation of 7-(arylalkoxy)coumarins as central nervous system agents. Ger. Offen. (1990), DE 3834861 A1 19900419.
57. Kong, L. D.; Tan, R. X.; Woo, A. Y.; Cheng, C. H. Inhibition of rat brain monoamine oxidase activities by psoralen and isopsoralen: implications for the treatment of affective disorders. Pharmacol. Toxicol, 2001, 88, 75-80.
58. Huong, D. T.; Choi, H. C; Rho, T. C; Lee, H. S.; Lee, M. K., Kim, Y. H. Inhibitory activity of monoamine oxidase by coumarins from Peucedanum japonicum. Arch. Pharm. Res., 1999, 22, 324-326.
59. Hossain, C. F.; Okuyama, E.; Yamazaki, M. A new series of coumarin derivatives having monoamine oxidase inhibitory activity from Monascus anka. Chem. Pharm. Bull, 1996, 44, 1535-1539.
60. Carotti, A.; Carrieri, A.; Chimichi, S.; Boccalini, M.; Cosimelli, B.; Gnerre, C; Carotti, A.; Carrupt, P.-A.; Testa, B. Natural and synthetic Geiparavins are strong and selective MAO-B inhibitors. Synthesis and SAR studies. Bioorg. Med. Chem. Lett., 2002, 12, 3551-3555.
61. Carotti, A.; Altomare, C; Catto, M.; Gnerre, C; Summo, L.; De Marco, A.; Rose, S.; Jenner, P.; Testa, B. Lipophilicity plays a major role in modulating the inhibition of monoamine oxidase B by 7- substituted coumarins. Chem. Biodivers., 2006, 3, 134-149.
62. Gnerre, C; Catto, M.; Francesco, L.; Weber, P.; Carrupt, P-A.; Altomare, C; Carotti, A.; Testa, B. Inhibition of monoamine oxidase by functionalized coumarin derivatives: biological activities, QSAR, and 3D-QSARs. J. Med. Chem., 2000, 43, 4747-4758.
63. Rendenbach-Müller, B; Schlecker, R.; Traut, M.; Weifenbach, H. Synthesis of coumarins as subtype-selective inhibitors of mono-amine oxidase inhibitors. Bioorg. Med. Chem. Lett, 1994, 4, 1195-1198.
64. Pisani, L.; Muncipinto, G.; Miscioscia, T. F.; Nicolotti, O.; Leon- etti, F.; Catto, M.; Caccia, C; Salvati, P.; Soto-Otero, R.; Mendez- Alvarez, E.; Passeleu, C; Carotti, A. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4- [(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor. J. Med. Chem., 2009, 52, 6685-6706.
65. Frickel, F.-F.; Kuekenhoehner, T.; Rendenbach-Müller, B.; Weifenbach, H.; Teschendforf, H.-J. Preparation of 7-(heterocyclylmethoxy)coumarins as monoamine oxidase inhibitors. Ger. Offen. (1990), DE 3834860 A1 19900419.
66. Santana, L.; González-Díaz, H.; Quezada, E.; Uriarte, E.; Yáñez, M.; Viña, D.; Orallo, F. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B in- hibitors. J. Med. Chem., 2008, 51, 6740-6751.
67. Catto, M.; Nicolotti, O.; Leonetti, F.; Carotti, A.; Favia, A. D.; Soto-Otero, R.; Méndez-Álvarez, E.; Carotti, A. Structural Insights into Monoamine Oxidase Inhibitory Potency and Selectivity of 7- Substituted Coumarins from Ligand- and Target-Based Approaches. J. Med.Chem., 2006, 49, 4912-4925.
68. Rendenbach-Müller, B.; Bulrich, K.; Weifenbach, H. [(Aryl)alkyloxy]thiocoumarins, process for their preparation and therapeutical agents containing them. Eur. Pat. Appl. (1994), EP 594036 A1 19940427.
69. Santana, L.; Orallo, F.; Viña, D.; Matos, M.J.; Quezada, E.; Yañez, M.; Vilar, S.; Uriarte, E. Use of 6-substituted 3-phenylcoumarins as selective monoamine oxidase B inhibitors for treating neurodegenerative diseases and obesity and preparation of new derivatives. Span. (2010), ES 2343347 A1 20100728.
70. Matos, M. J.; Viña, D.; Quezada, E.; Picciau, C.; Delogu, G.; Orallo, F.; Santana, L.; Uriarte, E. A new series of 3-phenyl coumarins as potent and selective MAO-B inhibitors. Bioorg. Med. Chem. Lett., 2009, 19, 3268-3270.
71. Matos, M. J.; Viña, D.; Picciau, C.; Orallo, F.; Santana, L.; Uriarte, E. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as po- tent and selective MAO-B inhibitors. Bioorg. Med. Chem. Lett., 2009, 19, 5053-5055.
72. Matos, M. J.; Terán, C.; Pérez-Castillo, Y.; Uriarte, E.; Santana, L.; Viña, D. Synthesis and Study of a Series of 3-Arylcoumarins as Po- tent and Selective Monoamine Oxidase B Inhibitors. J. Med. Chem., 2011, 54, 7127-7137.
73. Matos, M. J.; Vázquez-Rodriguez, S.; Uriarte, E.; Santana, L.; Viña, D. MAO inhibitory activity modulation: 3-phenylcoumarins versus 3-benzoylcoumarins. Bioorg. Med. Chem. Lett., 2011, 21, 4224-4227.
74. Viña, D.; Matos, M. J.; Yáñez, M.; Santana, L.; Uriarte, E. 3- Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimeŕs disease. Med. Chem. Commun., 2012, 3, 213-218.
75. Matos, M. J.; Viña, D.; Janeiro, P.; Borges, F.; Santana, L.; Uriarte, E. New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors. Bioorg. Med. Chem. Lett., 2010, 20, 5157-5160.
76. Viña, D.; Matos, M. J.; Ferino, G.; Cadoni, E.; Laguna, R.; Borges, F.; Uriarte, E.; Santana, L. 8-Substituted-3-arylcoumarins as Potent and Selective MAO-B Inhibitors: Synthesis, Pharmacological Evaluation and Docking Studies. ChemMedChem, 2012, 7, 464-470.
77. Serra, S.; Ferino, G.; Matos, M. J.; Vázquez-Rodríguez, S.; Delogu, G.; Viña, D.; Cadoni, E.; Santana, L.; Uriarte, E. Hydroxycoumar- ins as selective MAO-B inhibitors. Bioorg. Med. Chem. Lett., 2012, 22, 258-261.
78. Secci, D.; Carradori, S.; Bolasco, A.; Chimenti, P.; Yanez, M.; Ortuso, F.; Alcaro, S. Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives. Eur. J. Med. Chem., 2011, 46, 4846-4852.
79. Delogu, G.; Picciau, C.; Ferino, G.; Quezada, E.; Podda, G.; Uriarte, E.; Viña, D. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives. Eur. J. Med. Chem., 2011, 49, 1147-1152.
80. Chimenti, F.; Secci, D.; Bolasco, A.; Chimenti, P.; Granese, A.; Befani, O.; Turini, P.; Alcaro, S.; Ortuso, F. Inhibition of mono- amine oxidases by coumarin-3-acyl derivatives: biological activity and computational study. Bioorg. Med. Chem. Lett., 2004, 14, 3697-3703.
81. Chimenti, F.; Secci, D.; Bolasco, A.; Chimenti, P.; Bizarri, B.; Granese, A.; Carradori, S.; Yáñez, M.; Orallo, F.; Ortuso, F.; Alcaro, S. Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins. J. Med. Chem., 2009, 52, 1935-1942.
82. Brühlmann, C.; Ooms F.; Carrupt, P-A.; Testa, B.; Catto, M.; Leonetti, F.; Altomare, C.; Carotti, A. Coumarins derivatives as dual inhibitors of acethylcolinesterase and monoamine oxidase. J. Med. Chem., 2001, 44, 3195-3198.
83. Santana, L.; Uriarte, E.; González-Díaz, H.; Zagotto, G.; Soto- Otero, R.; Méndez-Álvarez, E. A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological as- say of novel coumarins. J. Med. Chem., 2006, 49, 1149-1156.
84. Binda, C.; Wang, J.; Pisani, L.; Caccia, C.; Carotti, A.; Salvati, P.; Edmondson, D.E.; Mattevi, A. Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J. Med. Chem., 2007, 50, 5848-5852.
85. Campos-Toimil, M.; Orallo, F.; Santana, L.; Uriarte, E. Synthesis and vasorelaxant activity of new coumarin and furocoumarin derivatives. Bioorg. Med. Chem. Lett. 2002, 12, 783-786.
86. Gao, Shu-T.; Li, C; Wang, Y; Ma, Jing-J; Wang, C; Zhang, Jing, W. NbCl5-catalyzed, solvent-free, one-pot synthesis of coumarins. Synth. Commun. 2011, 41, 1486-1491.
87. Suresh Kuarm, B.; Venu Madhav, J.; Vijaya Laxmi, S.; Rajitha, B.; Thirupathi Reddy, Y.; Narsimha Reddy, P.; Crooks, P. A. Expeditious Pechmann condensation by using biodegradable cellulose sulfuric acid as a solid acid catalyst. Synth. Commun., 2010, 40, 3358-3364.
88. Kumar, V.; Tomar, S.; Patel, R.; Yousaf, A.; Parmar, V. S.; Malhotra, S. V. FeCl3-catalyzed Pechmann synthesis of coumarins in ionic liquids. Synth. Commun., 2008, 38, 2646-2654.
89. Reddy, Y. T.; Sonar, V. N.; Crooks, P. A.; Dasari, P. K.; Reddy, P. N.; Rajitha, B. Ceric ammonium nitrate (CAN): An efficient catalyst for the coumarin synthesis via Pechmann condensation using conventional heating and microwave irradiation. Synth. Commun., 2008, 38, 2082-2088.
90. Timonen, J. M.; Nieminen, R. M.; Sareila, O.; Vainiotalo, P.; Moilanen, E.; Aulaskari, P. H. Synthesis and anti-inflammatory effects of a series of novel 7-hydroxycoumarin derivatives. Eur. J. Med. Chem., 2011, 46, 3845-3850.
91. Bakhchinian, R.; Terrier, F.; Kirkiacharian, S.; Resche-Rigon, M.; Bouchoux, F.; Cérède, E. Synthesis and relative binding affinity to human steroid receptors of substituted 3-aryloxycoumarins. Il Farmaco, 2003, 58, 1201-1207.
92. Darvatkar, N. B.; Deorukhkar, A. R.; Bhilare, S. V.; Raut, D. G.; Salunkhe, M. M. Ionic liquid-mediated synthesis of coumarin-3-carboxylic acids via Knoevenagel condensation of Meldrum's acid with ortho-hydroxyaryl aldehydes. Synth. Commun., 2008, 38, 3508-3513.
93. Frere, S.; Thiery, V.; Besson, T. Microwave acceleration of the Pechmann reaction on graphite/montmorillonite K10: application to the preparation of 4-substituted 7-aminocoumarins. Tetrahedron Lett., 2001, 42, 2791-2794.
94. Lal Dhar, Y.; Singh, S.; Rai, V. K. A one-pot [Bmim]OH- mediated synthesis of 3-benzamidocoumarins. Tetrahedron Lett., 2009,50, 2208-2212.
95. Mali, R. S.; Joshi, P. P. Useful syntheses of prenylated- and pyrano-3-arylcoumarins. Synth Commun., 2001, 31, 2753-2760.
96. Valizadeh, H.; Shockravi, A.; Heravi, M. M.; Ghadim, H. A. Microwave-induced in situ Wittig reaction of salicylaldehydes with ethyl chloroacetate and triphenylphosphine in solventless system. J. Chem. Res. Synop., 2003, 11, 718-720.
97. Mali, R. S.; Joshi, P. P. Useful syntheses of prenylated coumarins and pyrano-3-arylcoumarins. Synth. Commun., 2001, 31, 2753-2760.
98. Upadhyay, P. K.; Kumar, P. A novel synthesis of coumarins employing triphenyl(a-carboxymethylene)phosphorane imidazolide as a C-2 synthon. Tetrahedron Lett., 2009, 50, 236-238.
99. Harayama, T.; Katsuno, K.; Nishioka, H.; Fujii, M.; Nishita, Y.; Ishii, H.; Kaneko, Y. A convenient synthesis of a simple coumarin from salicyclaldehyde and Wittig reagent. I. A synthesis of methoxy-and hydroxycoumarins. Heterocycles, 1994, 392, 613-622.
100. Audisio, D.; Messaoudi, S.; Brion, J.-D.; Alami, M. A simple synthesis of functionalized 3-bromocoumarins by a one-pot three- component reaction. Eur. J. Org. Chem., 2010, (6), 1046-1051, S1046/1-S1046/18.
101. Kotani, M.; Yamamoto, K.; Oyamada, J.; Fujiwara, Y.; Kitamura, T. A convenient synthesis of coumarins by palladium(II)-catalyzed reaction of phenols with propiolic acids. Synthesis, 2004, 9, 1466-1470.
102. Li, K.; Zeng, Y.; Neuenswander, B.; Tunge, J. A. Sequential Pd (II)- Pd (0) catalysis for the rapid synthesis of coumarins. J. Org. Chem., 2005, 70, 6515-6518.
103. Fernandes, T. A.; Carvalho, R. C. C; Goncalves, T. M. D.; Costa, P.R. R. A tandem palladium-catalyzed Heck-lactonization through the reaction of ortho-iodophenols with p-substituted acrylates: synthesis of 4,6-substituted coumarins. Tetrahedron Lett., 2008, 49, 3322-3325.
104. Schiedel, M-S.; Briehn, C. A.; Bauerle, P. Single-compound libraries of organic materials: parallel synthesis and screening of fluorescent dyes. Angew. Chem. Int. Edit., 2001, 40, 4677-4680.
105. Matos, M. J.; Vazquez-Rodriguez, S.; Borges, F.; Santana, L.; Uriarte, E. Synthesis of 3-arylcoumarins via Suzuki-cross-coupling reactions of 3-chlorocoumarin. Tetrahedron Lett., 2011, 52, 1225-1227.
106. Rao, M. L. N.; Venkatesh, V.; Jadhav, D. N. Palladium-catalyzed synthesis of 4-arylcoumarins using triarylbismuth compounds as atom-efficient multicoupling organometallic nucleophiles. Eur. J. Org. Chem., 2010, 20, 3945-3955.
107. Wu, J.; Zhang, L.; Xia, H-G. Palladium-catalyzed Suzuki-Miyaura couplings of potassium aryl trifluoroborates with 4- tosyloxycoumarins or 4-tosyloxyquinolin-2(1H)-one. Tetrahedron Lett., 2006, 47, 1525-1528.
108. Zhang, Liang MT, Fan R A, Wu, J. General and efficient route for the synthesis of 3,4-disubstituted coumarins via Pd-catalyzed site-selective cross-coupling reactions. J.Org. Chem., 2007, 72, 7279-7286.